TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives August 29, 1975